Copyright © 2009 Ivan Monteleone et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. W. Strober, I. Fuss, and P. Mannon, “The fundamental basis of inflammatory bowel disease,” The Journal of Clinical Investigation, vol. 117, no. 3, pp. 514–521, 2007. View at Publisher · View at Google Scholar · View at PubMed
2. W. Strober, I. J. Fuss, and R. S. Blumberg, “The immunology of mucosal models of inflammation,” Annual Review of Immunology, vol. 20, pp. 495–549, 2002. View at Publisher · View at Google Scholar · View at PubMed
3. D. C. Baumgart and W. J. Sandborn, “Inflammatory bowel disease: clinical aspects and established and evolving therapies,” The Lancet, vol. 369, no. 9573, pp. 1641–1657, 2007. View at Publisher · View at Google Scholar · View at PubMed
4. H. Cheroutre and L. Madakamutil, “Acquired and natural memory T cells join forces at the mucosal front line,” Nature Reviews Immunology, vol. 4, no. 4, pp. 290–300, 2004. View at Publisher · View at Google Scholar · View at PubMed
5. G. Monteleone, L. Biancone, R. Marasco, et al., “Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells,” Gastroenterology, vol. 112, no. 4, pp. 1169–1178, 1997. View at Publisher · View at Google Scholar
6. M. F. Neurath, B. Weigmann, S. Finotto, et al., “The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease,” The Journal of Experimental Medicine, vol. 195, no. 9, pp. 1129–1143, 2002. View at Publisher · View at Google Scholar
7. I. J. Fuss, M. Neurath, M. Boirivant, et al., “Disparate $\text{CD}{4}^{+}$ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease: Crohn's disease LP cells manifest increased secretion of IFN-$\gamma$, whereas ulcerative colitis LP cells manifest increased secretion of IL-5,” The Journal of Immunology, vol. 157, no. 3, pp. 1261–1270, 1996.
8. F. Heller, P. Florian, C. Bojarski, et al., “Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution,” Gastroenterology, vol. 129, no. 2, pp. 550–564, 2005.
9. I. J. Fuss, F. Heller, M. Boirivant, et al., “Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis,” The Journal of Clinical Investigation, vol. 113, no. 10, pp. 1490–1497, 2004. View at Publisher · View at Google Scholar · View at PubMed
10. W. Ouyang, J. K. Kolls, and Y. Zheng, “The biological functions of T helper 17 cell effector cytokines in inflammation,” Immunity, vol. 28, no. 4, pp. 454–467, 2008. View at Publisher · View at Google Scholar · View at PubMed
11. D. McGovern and F. Powrie, “The IL23 axis plays a key role in the pathogenesis of IBD,” Gut, vol. 56, no. 10, pp. 1333–1336, 2007. View at Publisher · View at Google Scholar · View at PubMed
12. S. Fujino, A. Andoh, S. Bamba, et al., “Increased expression of interleukin 17 in inflammatory bowel disease,” Gut, vol. 52, no. 1, pp. 65–70, 2003. View at Publisher · View at Google Scholar
13. C. O. Elson, Y. Cong, C. T. Weaver, et al., “Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice,” Gastroenterology, vol. 132, no. 7, pp. 2359–2370, 2007. View at Publisher · View at Google Scholar · View at PubMed
14. E. Bettelli, T. Korn, M. Oukka, and V. K. Kuchroo, “Induction and effector functions of ${\text{T}}_{\text{H}}$17 cells,” Nature, vol. 453, no. 7198, pp. 1051–1057, 2008. View at Publisher · View at Google Scholar · View at PubMed
15. X. O. Yang, B. P. Pappu, R. Nurieva, et al., “T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR$\alpha$ and ROR$\gamma$,” Immunity, vol. 28, no. 1, pp. 29–39, 2008. View at Publisher · View at Google Scholar · View at PubMed
16. F. Zhang, G. Meng, and W. Strober, “Interactions among the transcription factors Runx1, ROR$\gamma$t and Foxp3 regulate the differentiation of interleukin 17-producing T cells,” Nature Immunology, vol. 9, no. 11, pp. 1297–1306, 2008. View at Publisher · View at Google Scholar · View at PubMed
17. A. R. Gocke, P. D. Cravens, L.-H. Ben, et al., “T-bet regulates the fate of Th1 and Th17 lymphocytes in autoimmunity,” The Journal of Immunology, vol. 178, no. 3, pp. 1341–1348, 2007.
18. H. Park, Z. Li, X. O. Yang, et al., “A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17,” Nature Immunology, vol. 6, no. 11, pp. 1133–1141, 2005. View at Publisher · View at Google Scholar · View at PubMed
19. L. E. Harrington, R. D. Hatton, P. R. Mangan, et al., “Interleukin 17-producing $\text{CD}{4}^{+}$ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages,” Nature Immunology, vol. 6, no. 11, pp. 1123–1132, 2005. View at Publisher · View at Google Scholar · View at PubMed
20. N. Manel, D. Unutmaz, and D. R. Littman, “The differentiation of human ${\text{T}}_{\text{H}}$-17 cells requires transforming growth factor-$\beta$ and induction of the nuclear receptor ROR$\gamma$t,” Nature Immunology, vol. 9, no. 6, pp. 641–649, 2008. View at Publisher · View at Google Scholar · View at PubMed
21. L. Xu, A. Kitani, I. Fuss, and W. Strober, “Cutting edge: regulatory T cells induce $\text{CD}{4}^{+}\text{CD}{25}^{-}\text{Foxp}{3}^{-}$ T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-$\beta$,” The Journal of Immunology, vol. 178, no. 11, pp. 6725–6729, 2007.
22. D. A. Horwitz, S. G. Zheng, and J. D. Gray, “Natural and TGF-$\beta$-induced $\text{Foxp}{3}^{+}$$\text{CD}{4}^{+}$$\text{CD}{25}^{+}$ regulatory T cells are not mirror images of each other,” Trends in Immunology, vol. 29, no. 9, pp. 429–435, 2008. View at Publisher · View at Google Scholar · View at PubMed
23. T. Korn, E. Bettelli, W. Gao, et al., “IL-21 initiates an alternative pathway to induce proinflammatory ${\text{T}}_{\text{H}}$17 cells,” Nature, vol. 448, no. 7152, pp. 484–487, 2007. View at Publisher · View at Google Scholar · View at PubMed
24. R. Nurieva, X.O. Yang, G. Martinez, et al., “Essential autocrine regulation by IL-21 in the generation of inflammatory T cells,” Nature, vol. 448, no. 7152, pp. 480–483, 2007. View at Publisher · View at Google Scholar · View at PubMed
25. L. Zhou, I. I. Ivanov, R. Spolski, et al., “IL-6 programs ${\text{T}}_{\text{H}}$-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways,” Nature Immunology, vol. 8, no. 9, pp. 967–974, 2007. View at Publisher · View at Google Scholar · View at PubMed
26. C. Sutton, C. Brereton, B. Keogh, K. H. G. Mills, and E. C. Lavelle, “A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis,” The Journal of Experimental Medicine, vol. 203, no. 7, pp. 1685–1691, 2006. View at Publisher · View at Google Scholar · View at PubMed
27. P. Ye, F. H. Rodriguez, S. Kanaly, et al., “Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense,” The Journal of Experimental Medicine, vol. 194, no. 4, pp. 519–527, 2001. View at Publisher · View at Google Scholar
28. W. Huang, L. Na, P. L. Fidel, and P. Schwarzenberger, “Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice,” The Journal of Infectious Diseases, vol. 190, no. 3, pp. 624–631, 2004. View at Publisher · View at Google Scholar · View at PubMed
29. K. Atarashi, J. Nishimura, T. Shima, et al., “ATP drives lamina propria ${\text{T}}_{\text{H}}$17 cell differentiation,” Nature, vol. 455, no. 7214, pp. 808–812, 2008. View at Publisher · View at Google Scholar · View at PubMed
30. M. Fukata, K. Breglio, A. Chen, et al., “The myeloid differentiation factor 88 (MyD88) is required for $\text{CD}{4}^{+}$ T cell effector function in a murine model of inflammatory bowel disease,” The Journal of Immunology, vol. 180, no. 3, pp. 1886–1894, 2008.
31. A. J. van Beelen, Z. Zelinkova, E. W. Taanman-Kueter, et al., “Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells,” Immunity, vol. 27, no. 4, pp. 660–669, 2007. View at Publisher · View at Google Scholar · View at PubMed
32. F. Osorio, S. LeibundGut-Landmann, M. Lochner, et al., “DC activated via dectin-1 convert Treg into IL-17 producers,” European Journal of Immunology, vol. 38, no. 12, pp. 3274–3281, 2008. View at Publisher · View at Google Scholar · View at PubMed
33. J. S. Stumhofer, J. S. Silver, A. Laurence, et al., “Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10,” Nature Immunology, vol. 8, no. 12, pp. 1363–1371, 2007. View at Publisher · View at Google Scholar · View at PubMed
34. M. J. McGeachy, K. S. Bak-Jensen, Y. Chen, et al., “TGF-$\beta$ and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain ${\text{T}}_{\text{H}}$-17 cell-mediated pathology,” Nature Immunology, vol. 8, no. 12, pp. 1390–1397, 2007. View at Publisher · View at Google Scholar · View at PubMed
35. S. Bamba, A. Andoh, H. Yasui, Y. Araki, T. Bamba, and Y. Fujiyama, “Matrix metalloproteinase-3 secretion from human colonic subepithelial myofibroblasts: role of interleukin-17,” Journal of Gastroenterology, vol. 38, no. 6, pp. 548–554, 2003.
36. J. Seiderer, I. Elben, J. Diegelmann, et al., “Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD,” Inflammatory Bowel Diseases, vol. 14, no. 4, pp. 437–445, 2008. View at Publisher · View at Google Scholar · View at PubMed
37. F. Annunziato, L. Cosmi, V. Santarlasci, et al., “Phenotypic and functional features of human Th17 cells,” The Journal of Experimental Medicine, vol. 204, no. 8, pp. 1849–1861, 2007. View at Publisher · View at Google Scholar · View at PubMed
38. T. Kobayashi, S. Okamoto, T. Hisamatsu, et al., “IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease,” Gut, vol. 57, no. 12, pp. 1682–1689, 2008. View at Publisher · View at Google Scholar · View at PubMed
39. G. Monteleone, I. Monteleone, D. Fina, et al., “Interleukin-21 enhances T-helper cell type I signaling and interferon-$\gamma$ production in Crohn's disease,” Gastroenterology, vol. 128, no. 3, pp. 687–694, 2005. View at Publisher · View at Google Scholar
40. G. Monteleone, R. Caruso, D. Fina, et al., “Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21,” Gut, vol. 55, no. 12, pp. 1774–1780, 2006. View at Publisher · View at Google Scholar · View at PubMed
41. R. Caruso, D. Fina, I. Peluso, et al., “A functional role for interleukin-21 in promoting the synthesis of the T-cell chemoattractant, MIP-3$\alpha$, by gut epithelial cells,” Gastroenterology, vol. 132, no. 1, pp. 166–175, 2007. View at Publisher · View at Google Scholar · View at PubMed
42. A. Andoh, Z. Zhang, O. Inatomi, et al., “Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts,” Gastroenterology, vol. 129, no. 3, pp. 969–984, 2005. View at Publisher · View at Google Scholar · View at PubMed
43. S. Brand, F. Beigel, T. Olszak, et al., “IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration,” American Journal of Physiology, vol. 290, no. 4, pp. G827–G838, 2006. View at Publisher · View at Google Scholar · View at PubMed
44. M. Chabaud, J. M. Durand, N. Buchs, et al., “Human interleukin-17: a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium,” Arthritis and Rheumatism, vol. 42, no. 5, pp. 963–970, 1999. View at Publisher · View at Google Scholar
45. C. Lock, G. Hermans, R. Pedotti, et al., “Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis,” Nature Medicine, vol. 8, no. 5, pp. 500–508, 2002. View at Publisher · View at Google Scholar · View at PubMed
46. N. J. Wilson, K. Boniface, J. R. Chan, et al., “Development, cytokine profile and function of human interleukin 17-producing helper T cells,” Nature Immunology, vol. 8, no. 9, pp. 950–957, 2007. View at Publisher · View at Google Scholar · View at PubMed
47. K. Sato, A. Suematsu, K. Okamoto, et al., “Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction,” The Journal of Experimental Medicine, vol. 203, no. 12, pp. 2673–2682, 2006. View at Publisher · View at Google Scholar · View at PubMed
48. Y. Zheng, D. M. Danilenko, P. Valdez, et al., “Interleukin-22, a ${\text{T}}_{\text{H}}$17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis,” Nature, vol. 445, no. 7128, pp. 648–651, 2007. View at Publisher · View at Google Scholar · View at PubMed
49. H. Kebir, K. Kreymborg, I. Ifergan, et al., “Human ${\text{T}}_{\text{H}}$ lymphocytes promote blood-brain barrier disruption and central nervous system inflammation,” Nature Medicine, vol. 13, no. 10, pp. 1173–1175, 2007. View at Publisher · View at Google Scholar · View at PubMed
50. Z. Zhang, M. Zheng, J. Bindas, P. Schwarzenberger, and J. K. Kolls, “Critical role of IL-17 receptor signaling in acute TNBS-induced colitis,” Inflammatory Bowel Diseases, vol. 12, no. 5, pp. 382–388, 2006. View at Publisher · View at Google Scholar · View at PubMed
51. T. A. Moseley, D. R. Haudenschild, L. Rose, and A. H. Reddi, “Interleukin-17 family and IL-17 receptors,” Cytokine and Growth Factor Reviews, vol. 14, no. 2, pp. 155–174, 2003. View at Publisher · View at Google Scholar
52. X. O. Yang, S. H. Chang, H. Park, et al., “Regulation of inflammatory responses by IL-17F,” The Journal of Experimental Medicine, vol. 205, no. 5, pp. 1063–1075, 2008. View at Publisher · View at Google Scholar · View at PubMed
53. M. Tajima, D. Wakita, D. Noguchi, et al., “IL-6-dependent spontaneous proliferation is required for the induction of colitogenic IL-17-producing $\text{CD}{8}^{+}$ T cells,” The Journal of Experimental Medicine, vol. 205, no. 5, pp. 1019–1027, 2008. View at Publisher · View at Google Scholar · View at PubMed
54. D. Fina, M. Sarra, M. C. Fantini, et al., “Regulation of gut inflammation and Th17 cell response by interleukin-21,” Gastroenterology, vol. 134, no. 4, pp. 1038–1048, 2008. View at Publisher · View at Google Scholar · View at PubMed
55. B. Oppmann, R. Lesley, B. Blom, et al., “Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12,” Immunity, vol. 13, no. 5, pp. 715–725, 2000. View at Publisher · View at Google Scholar
56. C. Schmidt, T. Giese, B. Ludwig, et al., “Expression of interleukin-12-related cytokine transcripts in inflammatory bowel disease: elevated interleukin-23p19 and interleukin-27p28 in Crohn's disease but not in ulcerative colitis,” Inflammatory Bowel Diseases, vol. 11, no. 1, pp. 16–23, 2005. View at Publisher · View at Google Scholar
57. N. Kamada, T. Hisamatsu, S. Okamoto, et al., “Unique $\text{CD}{14}^{+}$ intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-$\gamma$ axis,” The Journal of Clinical Investigation, vol. 118, no. 6, pp. 2269–2280, 2008.
58. P. J. Mannon, I. J. Fuss, L. Mayer, et al., “Anti-interleukin-12 antibody for active Crohn's disease,” The New England Journal of Medicine, vol. 351, no. 20, pp. 2069–2079, 2004. View at Publisher · View at Google Scholar · View at PubMed
59. D. Yen, J. Cheung, H. Scheerens, et al., “IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6,” The Journal of Clinical Investigation, vol. 116, no. 5, pp. 1310–1316, 2006. View at Publisher · View at Google Scholar · View at PubMed
60. H. H. Uhlig, B. S. McKenzie, S. Hue, et al., “Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology,” Immunity, vol. 25, no. 2, pp. 309–318, 2006. View at Publisher · View at Google Scholar · View at PubMed
61. A. Izcue, S. Hue, S. Buonocore, et al., “Interleukin-23 restrains regulatory T cell activity to drive T cell-dependent colitis,” Immunity, vol. 28, no. 4, pp. 559–570, 2008. View at Publisher · View at Google Scholar · View at PubMed
62. D. Noguchi, D. Wakita, M. Tajima, et al., “Blocking of IL-6 signaling pathway prevents $\text{CD}{4}^{+}$ T cell-mediated colitis in a ${\text{T}}_{\text{h}}$17-independent manner,” International Immunology, vol. 19, no. 12, pp. 1431–1440, 2007. View at Publisher · View at Google Scholar · View at PubMed
63. C. Becker, H. Dornhoff, C. Neufert, et al., “Cutting edge: IL-23 cross-regulates IL-12 production in T cell-dependent experimental colitis,” The Journal of Immunology, vol. 177, no. 5, pp. 2760–2764, 2006.
64. R. H. Duerr, K. D. Taylor, S. R. Brant, et al., “A genome-wide association study identifies IL23R as an inflammatory bowel disease gene,” Science, vol. 314, no. 5804, pp. 1461–1463, 2006. View at Publisher · View at Google Scholar · View at PubMed
65. H. Ito, M. Takazoe, Y. Fukuda, et al., “A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease,” Gastroenterology, vol. 126, no. 4, pp. 989–996, 2004. View at Publisher · View at Google Scholar
66. E. Bettelli, Y. Carrier, W. Gao, et al., “Reciprocal developmental pathways for the generation of pathogenic effector ${\text{T}}_{\text{H}}$17 and regulatory T cells,” Nature, vol. 441, no. 7090, pp. 235–238, 2006. View at Publisher · View at Google Scholar · View at PubMed